Aginko is the Credit Impot Recherche accredited CRO specialized in osteoarticular pathologies and medical devices We help create maximum value for your company.
Our Vision is to be the CRO of choice for all Musculosketal Research Projects from pre-clinical to clinical and regulatory studies, helping musculoskeletal companies achieve maximum value for all stakeholders. AGINKO’s mission is to provide the best quality pre-clinical laboratory services and clinical trial management for our clients in the pharmaceutical, biotechnological and medical device industries. This mission is achieved through our commitment to customer service and scientific quality. We employ a team of experienced musculoskeletal experts who help guide your orthopaedic products or compounds through the regulatory pre-clinical and clinical processes quickly and successfully.
18/06/2020
Aginko's pathology and histology experts offer preclinical histopathology of COVID Vaccines
Preclinical histopathology of vaccine candidates focuses on safety of the vaccine by evaluating tissue changes after administration in animals, not only on the site of administration but in all other tissue to make sure there are not unwanted consequences.
Aginko's pathologists assess safety changes associated with vaccination protocols.
09/04/2020
Aginko Research wishes you all a happy Easter !!!
And stay safe.
02/04/2020
Update on Aginko activities - COVID 19
Dear Clients and Partners,
As promised, we are continuing to keep you updated on Aginko's activities during these unprecedented times.
Aginko's concern, first and foremost, is for the health and safety of our collaborators, consultant and clients.
Even, if some of the futures projects are in stand-bay for instance, our team is working on ongoing projects, shifting to a home-based work model and limited presence in our laboratories.
Moreover, this period motivated to overcome ourselves in order to find new solutions trying to combat the COVID-19 pandemic situation.
Thus, Aginko has already developed two products that are intended to prevent the spread of this type of virus and will continue to innovate in order to set up a contengy plan.
We can start already to disscus and prepare with you on our preclinical models dedicated to test future medical devices and treatments develped to eliminate COVID-19 or our core excellence, OA, Cartilage, RA, Pain, Bone fracture Medical devices testing or histological services.
There is no better time to strengthen our bonds, to help each other through this storm and come out the other side stronger.
Take care of yourself and your loved ones !
Yours Faithfully,
Your Aginko team.
23/01/2020
Aginko can support your , discover our wide choice of : www.aginko.com
15/01/2020
at the John Hopkins University School of Medicine say they have added to the evidence that age-related changes to tissue could invite painful nerve overgrowth that causes lower back .
Read full article : https://go.nature.com/35WSHiG.
Aginko can support your research, visit our website for more information: www.aginko.com
Spinal pain is a major clinical problem. Here the authors show that osteoclasts create porous area of endplates of the vertebrae and sensory innervation of porous endplates by Netrin-1 release from osteoclasts mediates PGE2-induced spinal hypersensitivity in mice.
30/12/2019
Aginko Research AG wishes you a Wonderful Holiday Season and a Happy New Year !
23/12/2019
Merry Christmas from the Aginko Research AG Team ! We hope you have a wonderful festive season !
11/12/2019
Substantive molecular and changes within the meniscus with tears. Read more : https://bit.ly/2LLQIX5.
Aginko can support your research, visit our website for more information: www.aginko.com
06/12/2019
This quantify sensory and motor deficits in collagen-induced ( ) during natural disease progression and therapeutic treatment. Read full article : https://bit.ly/2DYeril.
Aginko can support your research, visit our website for more information: www.aginko.com
In the collagen-induced arthritis (CIA) mouse model, inflammation readouts are usually quantified using operator-dependent clinical scoring systems, and no systematic relationship with functional deficits has been detected. In this study, we extensively quantified sensory and motor deficits in CIA m...
15/11/2019
Bone marrow mesenchymal stem cells in , spondyloarthritis, and ankylosing spondylitis: problems rather than solutions? Read full article : https://bit.ly/2XghPhy
Aginko can support your research, visit our website for more information: www.aginko.com
Bone marrow mesenchymal stem cells (BM-MSCs) can dampen inflammation in animal models of inflammatory rheumatisms and human osteoarthritis. They are expected to be a solution for numerous human conditions. However, in rheumatoid arthritis (RA) and spondyloarthritis (SpA), subsets of subchondral BM-M...
12/11/2019
This article shows that virtual reality can be used to reduce sensitivity. Read full article : https://bit.ly/2K9PpQP.
Aginko can support your research, visit our website for more information: www.aginko.com
Watching immersive 360 videos of icy Arctic scenes helps to relieve burning pain and could hold hope for treating chronic pain, a study has found.
05/11/2019
Identifying the role of Asporin (ASPN) and Cartilage oligomeric matrix protein (COMP) ) genes in development. Read full article : https://bit.ly/2oS5Wlg.
Aginko can support your research, visit our website for more information: www.aginko.com
Adresse
Route De L'ancienne Papeterie 7 Marly-le-Grand 1723
Lassen Sie sich von uns eine E-Mail senden und seien Sie der erste der Neuigkeiten und Aktionen von Aginko Research AG erfährt. Ihre E-Mail-Adresse wird nicht für andere Zwecke verwendet und Sie können sich jederzeit abmelden.
Your Partner of Choice for Projects in Bone and Joint Diseases
AGINKO Research is a unique osteoarticular and inflammation focused preclinical and clinical research organization with an unrivaled reputation for conducting global studies and development programs of the highest integrity.
Our clients (pharmaceutical, biotechnology and medical device companies) rely on us to conduct world-class preclinical and clinical programs in the field of bone, cartilage, spine, inflammation, and pain.
In these areas, in particular, we offer broad study experience and direct knowledge of study requirements, risk management, and best practice implementation.
We offer effective study design and management services, multi-service integration, and an efficient process that reduces delays and gives clients confidence and peace of mind.
By combining the AGINKO Research methodology with therapeutic expertise, sponsors can decide with confidence due to improved information about drugs and device development. AGINKO Research’s headquarters are situated in Marly, Fribourg, SWITZERLAND.